Cargando…
Bacteriomimetic Liposomes Improve Antibiotic Activity of a Novel Energy-Coupling Factor Transporter Inhibitor
Liposomes have been studied for decades as nanoparticulate drug delivery systems for cytostatics, and more recently, for antibiotics. Such nanoantibiotics show improved antibacterial efficacy compared to the free drug and can be effective despite bacterial recalcitrance. In this work, we present a l...
Autores principales: | Drost, Menka, Diamanti, Eleonora, Fuhrmann, Kathrin, Goes, Adriely, Shams, Atanaz, Haupenthal, Jörg, Koch, Marcus, Hirsch, Anna K. H., Fuhrmann, Gregor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779172/ https://www.ncbi.nlm.nih.gov/pubmed/35056900 http://dx.doi.org/10.3390/pharmaceutics14010004 |
Ejemplares similares
-
An Efficient Way to Screen Inhibitors of Energy-Coupling Factor (ECF) Transporters in a Bacterial Uptake Assay
por: Bousis, Spyridon, et al.
Publicado: (2022) -
Structure-Guided
Optimization of Small-Molecule Folate
Uptake Inhibitors Targeting the Energy-Coupling Factor Transporters
por: Kiefer, Alexander F., et al.
Publicado: (2022) -
Myxobacteria-Derived Outer Membrane Vesicles: Potential Applicability Against Intracellular Infections
por: Goes, Adriely, et al.
Publicado: (2020) -
Identification of inhibitors targeting the energy-coupling factor (ECF) transporters
por: Diamanti, Eleonora, et al.
Publicado: (2023) -
Tracking matricellular protein SPARC in extracellular vesicles as a non-destructive method to evaluate lipid-based antifibrotic treatments
por: Zivko, Cristina, et al.
Publicado: (2022)